Elisabetta Patorno

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Poster(s):

• (53) Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Metformin as First-Line Treatment for Type 2 Diabetes
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (49) Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) Versus Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in T2D Patients Across Different HbA1c Levels
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (219) Exposure to Non-Insulin 2nd-Line Antidiabetic Medications in Early Pregnancy and Risk of Major Congenital Malformations
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (267) Real-World Continuous Glucose Monitoring in Adults with Type 1 and Type 2 Diabetes
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST